<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30334522</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>26</Day></DateCompleted><DateRevised><Year>2019</Year><Month>05</Month><Day>23</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2050-084X</ISSN><JournalIssue CitedMedium="Internet"><Volume>7</Volume><PubDate><Year>2018</Year><Month>Oct</Month><Day>18</Day></PubDate></JournalIssue><Title>eLife</Title><ISOAbbreviation>Elife</ISOAbbreviation></Journal><ArticleTitle>Epitope resurfacing on dengue virus-like particle vaccine preparation to induce broad neutralizing antibody.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">e38970</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7554/eLife.38970</ELocationID><Abstract><AbstractText>Dengue fever is caused by four different serotypes of dengue virus (DENV) which is the leading cause of worldwide arboviral diseases in humans. Virus-like particles (VLPs) containing flavivirus prM/E proteins have been demonstrated to be a potential vaccine candidate; however, the structure of dengue VLP is poorly understood. Herein VLP derived from DENV serotype-2 were engineered becoming highly matured (mD2VLP) and showed variable size distribution with diameter of ~31 nm forming the major population under cryo-electron microscopy examination. Furthermore, mD2VLP particles of 31 nm diameter possess a T = 1 icosahedral symmetry with a groove located within the E-protein dimers near the 2-fold vertices that exposed highly overlapping, cryptic neutralizing epitopes. Mice vaccinated with mD2VLP generated higher cross-reactive (CR) neutralization antibodies (NtAbs) and were fully protected against all 4 serotypes of DENV. Our results highlight the potential of 'epitope-resurfaced' mature-form D2VLPs in inducing quaternary structure-recognizing broad CR NtAbs to guide future dengue vaccine design.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Shen</LastName><ForeName>Wen-Fan</ForeName><Initials>WF</Initials><AffiliationInfo><Affiliation>Microbial Genomics Ph.D. Program, National Chung Hsing University and Academia Sinica, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Galula</LastName><ForeName>Jedhan Ucat</ForeName><Initials>JU</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liu</LastName><ForeName>Jyung-Hurng</ForeName><Initials>JH</Initials><Identifier Source="ORCID">0000-0002-7173-0372</Identifier><AffiliationInfo><Affiliation>Institute of Genomics and Bioinformatics, College of Life Science, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Liao</LastName><ForeName>Mei-Ying</ForeName><Initials>MY</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Huang</LastName><ForeName>Cheng-Hao</ForeName><Initials>CH</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yu-Chun</ForeName><Initials>YC</Initials><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Han-Chung</ForeName><Initials>HC</Initials><Identifier Source="ORCID">0000-0002-5185-1169</Identifier><AffiliationInfo><Affiliation>Institute of Cellular and Organismic Biology, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liang</LastName><ForeName>Jian-Jong</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lin</LastName><ForeName>Yi-Ling</ForeName><Initials>YL</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Whitney</LastName><ForeName>Matthew T</ForeName><Initials>MT</Initials><AffiliationInfo><Affiliation>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Gwong-Jen J</ForeName><Initials>GJ</Initials><Identifier Source="ORCID">0000-0001-9959-6585</Identifier><AffiliationInfo><Affiliation>Division of Vector-Borne Diseases, Centers for Disease Control and Prevention, Fort Collins, Colorado, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Sheng-Ren</ForeName><Initials>SR</Initials><AffiliationInfo><Affiliation>Institute of Oral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Shang-Rung</ForeName><Initials>SR</Initials><Identifier Source="ORCID">0000-0003-1940-7612</Identifier><AffiliationInfo><Affiliation>Institute of Oral Medicine, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Basic Medical Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Chao</LastName><ForeName>Day-Yu</ForeName><Initials>DY</Initials><Identifier Source="ORCID">0000-0001-7139-026X</Identifier><AffiliationInfo><Affiliation>Graduate Institute of Microbiology and Public Health, College of Veterinary Medicine, National Chung-Hsing University, Taichung City, Taiwan.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>10</Month><Day>18</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Elife</MedlineTA><NlmUniqueID>101579614</NlmUniqueID><ISSNLinking>2050-084X</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000911">Antibodies, Monoclonal</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D057134">Antibodies, Neutralizing</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D053059">Dengue Vaccines</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000939">Epitopes</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D012997">Solvents</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D058425">Vaccines, Virus-Like Particle</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014759">Viral Envelope Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C074932">prM protein, Flavivirus</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000911" MajorTopicYN="N">Antibodies, Monoclonal</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D057134" MajorTopicYN="N">Antibodies, Neutralizing</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D053059" MajorTopicYN="N">Dengue Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D003716" MajorTopicYN="N">Dengue Virus</DescriptorName><QualifierName UI="Q000145" MajorTopicYN="N">classification</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000939" MajorTopicYN="N">Epitopes</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008807" MajorTopicYN="N">Mice, Inbred BALB C</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012703" MajorTopicYN="N">Serotyping</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012997" MajorTopicYN="N">Solvents</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016019" MajorTopicYN="N">Survival Analysis</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D058425" MajorTopicYN="N">Vaccines, Virus-Like Particle</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014759" MajorTopicYN="N">Viral Envelope Proteins</DescriptorName><QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014771" MajorTopicYN="N">Virion</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName><QualifierName UI="Q000648" MajorTopicYN="N">ultrastructure</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">broad antibody response</Keyword><Keyword MajorTopicYN="N">cryoEM</Keyword><Keyword MajorTopicYN="N">dengue</Keyword><Keyword MajorTopicYN="N">infectious disease</Keyword><Keyword MajorTopicYN="N">microbiology</Keyword><Keyword MajorTopicYN="N">molecular biophysics</Keyword><Keyword MajorTopicYN="N">mouse</Keyword><Keyword MajorTopicYN="N">structural biology</Keyword><Keyword MajorTopicYN="N">vaccine</Keyword><Keyword MajorTopicYN="N">virus</Keyword><Keyword MajorTopicYN="N">virus-like particle</Keyword></KeywordList><CoiStatement>WS, JG, JL, ML, CH, YW, HW, JL, YL, MW, GC, SC, SW, DC No competing interests declared</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>6</Month><Day>6</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>10</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>10</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>27</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>10</Month><Day>19</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30334522</ArticleId><ArticleId IdType="pmc">PMC6234032</ArticleId><ArticleId IdType="doi">10.7554/eLife.38970</ArticleId><ArticleId IdType="pii">38970</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Aguiar M, Stollenwerk N, Halstead SB. The Impact of the Newly Licensed Dengue Vaccine in Endemic Countries. PLoS Neglected Tropical Diseases. 2016;10:e0005179. doi: 10.1371/journal.pntd.0005179.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0005179</ArticleId><ArticleId IdType="pmc">PMC5176165</ArticleId><ArticleId IdType="pubmed">28002420</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison SL, Stadler K, Mandl CW, Kunz C, Heinz FX. Synthesis and secretion of recombinant tick-borne encephalitis virus protein E in soluble and particulate form. Journal of Virology. 1995;69:5816&#x2013;5820.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC189449</ArticleId><ArticleId IdType="pubmed">7637027</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatt S, Gething PW, Brady OJ, Messina JP, Farlow AW, Moyes CL, Drake JM, Brownstein JS, Hoen AG, Sankoh O, Myers MF, George DB, Jaenisch T, Wint GR, Simmons CP, Scott TW, Farrar JJ, Hay SI. The global distribution and burden of dengue. Nature. 2013;496:504&#x2013;507. doi: 10.1038/nature12060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12060</ArticleId><ArticleId IdType="pmc">PMC3651993</ArticleId><ArticleId IdType="pubmed">23563266</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavallo L, Kleinjung J, Fraternali F. POPS: a fast algorithm for solvent accessible surface areas at atomic and residue level. Nucleic Acids Research. 2003;31:3364&#x2013;3366. doi: 10.1093/nar/gkg601.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkg601</ArticleId><ArticleId IdType="pmc">PMC169007</ArticleId><ArticleId IdType="pubmed">12824328</ArticleId></ArticleIdList></Reference><Reference><Citation>Chambers TJ, Hahn CS, Galler R, Rice CM. Flavivirus genome organization, expression, and replication. Annual Review of Microbiology. 1990;44:649&#x2013;688. doi: 10.1146/annurev.mi.44.100190.003245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.mi.44.100190.003245</ArticleId><ArticleId IdType="pubmed">2174669</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang GJ, Hunt AR, Davis B. A single intramuscular injection of recombinant plasmid DNA induces protective immunity and prevents Japanese encephalitis in mice. Journal of Virology. 2000;74:4244&#x2013;4252. doi: 10.1128/JVI.74.9.4244-4252.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.74.9.4244-4252.2000</ArticleId><ArticleId IdType="pmc">PMC111940</ArticleId><ArticleId IdType="pubmed">10756038</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang GJ, Hunt AR, Holmes DA, Springfield T, Chiueh TS, Roehrig JT, Gubler DJ. Enhancing biosynthesis and secretion of premembrane and envelope proteins by the chimeric plasmid of dengue virus type 2 and Japanese encephalitis virus. Virology. 2003;306:170&#x2013;180. doi: 10.1016/S0042-6822(02)00028-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0042-6822(02)00028-4</ArticleId><ArticleId IdType="pubmed">12620809</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YC, Huang HN, Lin CT, Chen YF, King CC, Wu HC. Generation and characterization of monoclonal antibodies against dengue virus type 1 for epitope mapping and serological detection by epitope-based peptide antigens. Clinical and Vaccine Immunology. 2007;14:404&#x2013;411. doi: 10.1128/CVI.00249-06.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00249-06</ArticleId><ArticleId IdType="pmc">PMC1865613</ArticleId><ArticleId IdType="pubmed">17287314</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen HW, Liu SJ, Li YS, Liu HH, Tsai JP, Chiang CY, Chen MY, Hwang CS, Huang CC, Hu HM, Chung HH, Wu SH, Chong P, Leng CH, Pan CH. A consensus envelope protein domain III can induce neutralizing antibody responses against serotype 2 of dengue virus in non-human primates. Archives of Virology. 2013;158:1523&#x2013;1531. doi: 10.1007/s00705-013-1639-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-013-1639-1</ArticleId><ArticleId IdType="pubmed">23456422</ArticleId></ArticleIdList></Reference><Reference><Citation>Cherrier MV, Kaufmann B, Nybakken GE, Lok SM, Warren JT, Chen BR, Nelson CA, Kostyuchenko VA, Holdaway HA, Chipman PR, Kuhn RJ, Diamond MS, Rossmann MG, Fremont DH. Structural basis for the preferential recognition of immature flaviviruses by a fusion-loop antibody. The EMBO Journal. 2009;28:3269&#x2013;3276. doi: 10.1038/emboj.2009.245.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/emboj.2009.245</ArticleId><ArticleId IdType="pmc">PMC2771083</ArticleId><ArticleId IdType="pubmed">19713934</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill WD, Hughes HR, Delorey MJ, Chang GJ. Humoral immune responses of dengue fever patients using epitope-specific serotype-2 virus-like particle antigens. PLoS One. 2009;4:e4991. doi: 10.1371/journal.pone.0004991.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0004991</ArticleId><ArticleId IdType="pmc">PMC2659788</ArticleId><ArticleId IdType="pubmed">19337372</ArticleId></ArticleIdList></Reference><Reference><Citation>Crill WD, Hughes HR, Trainor NB, Davis BS, Whitney MT, Chang GJ. Sculpting humoral immunity through dengue vaccination to enhance protective immunity. Frontiers in Immunology. 2012;3:334. doi: 10.3389/fimmu.2012.00334.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2012.00334</ArticleId><ArticleId IdType="pmc">PMC3492872</ArticleId><ArticleId IdType="pubmed">23162552</ArticleId></ArticleIdList></Reference><Reference><Citation>Crowe JE. Principles of broad and potent antiviral human antibodies: insights for vaccine design. Cell Host &amp; Microbe. 2017;22:193&#x2013;206. doi: 10.1016/j.chom.2017.07.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2017.07.013</ArticleId><ArticleId IdType="pmc">PMC5700460</ArticleId><ArticleId IdType="pubmed">28799905</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Voorham JM, Rodenhuis-Zybert IA, Ayala Nu&#xf1;ez NV, Colpitts TM, van der Ende-Metselaar H, Fikrig E, Diamond MS, Wilschut J, Smit JM. Antibodies against the envelope glycoprotein promote infectivity of immature dengue virus serotype 2. PLoS One. 2012;7:e29957. doi: 10.1371/journal.pone.0029957.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0029957</ArticleId><ArticleId IdType="pmc">PMC3303773</ArticleId><ArticleId IdType="pubmed">22431958</ArticleId></ArticleIdList></Reference><Reference><Citation>de Alwis R, Beltramello M, Messer WB, Sukupolvi-Petty S, Wahala WM, Kraus A, Olivarez NP, Pham Q, Brien JD, Brian J, Tsai WY, Wang WK, Halstead S, Kliks S, Diamond MS, Baric R, Lanzavecchia A, Sallusto F, de Silva AM. In-depth analysis of the antibody response of individuals exposed to primary dengue virus infection. PLoS Neglected Tropical Diseases. 2011;5:e1188. doi: 10.1371/journal.pntd.0001188.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001188</ArticleId><ArticleId IdType="pmc">PMC3119640</ArticleId><ArticleId IdType="pubmed">21713020</ArticleId></ArticleIdList></Reference><Reference><Citation>de la Rosa-Trev&#xed;n JM, Ot&#xf3;n J, Marabini R, Zald&#xed;var A, Vargas J, Carazo JM, Sorzano CO. Xmipp 3.0: an improved software suite for image processing in electron microscopy. Journal of Structural Biology. 2013;184:321&#x2013;328. doi: 10.1016/j.jsb.2013.09.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2013.09.015</ArticleId><ArticleId IdType="pubmed">24075951</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Jumnainsong A, Onsirisakul N, Fitton P, Vasanawathana S, Limpitikul W, Puttikhunt C, Edwards C, Duangchinda T, Supasa S, Chawansuntati K, Malasit P, Mongkolsapaya J, Screaton G. Cross-reacting antibodies enhance dengue virus infection in humans. Science. 2010;328:745&#x2013;748. doi: 10.1126/science.1185181.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1185181</ArticleId><ArticleId IdType="pmc">PMC3837288</ArticleId><ArticleId IdType="pubmed">20448183</ArticleId></ArticleIdList></Reference><Reference><Citation>Dejnirattisai W, Wongwiwat W, Supasa S, Zhang X, Dai X, Rouvinski A, Jumnainsong A, Edwards C, Quyen NTH, Duangchinda T, Grimes JM, Tsai WY, Lai CY, Wang WK, Malasit P, Farrar J, Simmons CP, Zhou ZH, Rey FA, Mongkolsapaya J, Screaton GR. A new class of highly potent, broadly neutralizing antibodies isolated from viremic patients infected with dengue virus. Nature Immunology. 2015;16:170&#x2013;177. doi: 10.1038/ni.3058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ni.3058</ArticleId><ArticleId IdType="pmc">PMC4445969</ArticleId><ArticleId IdType="pubmed">25501631</ArticleId></ArticleIdList></Reference><Reference><Citation>Eswar N, Webb B, Marti-Renom MA, Madhusudhan MS, Eramian D, Shen MY, Pieper U, Sali A. Comparative protein structure modeling using MODELLER. Current Protocols in Protein Science. 2007;50:2.9.1&#x2013;2.9.2. doi: 10.1002/0471140864.ps0209s50.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/0471140864.ps0209s50</ArticleId><ArticleId IdType="pubmed">18429317</ArticleId></ArticleIdList></Reference><Reference><Citation>Ferlenghi I, Clarke M, Ruttan T, Allison SL, Schalich J, Heinz FX, Harrison SC, Rey FA, Fuller SD. Molecular organization of a recombinant subviral particle from tick-borne encephalitis virus. Molecular Cell. 2001;7:593&#x2013;602. doi: 10.1016/S1097-2765(01)00206-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1097-2765(01)00206-4</ArticleId><ArticleId IdType="pubmed">11463384</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibriansah G, Ibarra KD, Ng TS, Smith SA, Tan JL, Lim XN, Ooi JS, Kostyuchenko VA, Wang J, de Silva AM, Harris E, Crowe JE, Lok SM. DENGUE VIRUS. Cryo-EM structure of an antibody that neutralizes dengue virus type 2 by locking E protein dimers. Science. 2015a;349:88&#x2013;91. doi: 10.1126/science.aaa8651.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.aaa8651</ArticleId><ArticleId IdType="pmc">PMC4672004</ArticleId><ArticleId IdType="pubmed">26138979</ArticleId></ArticleIdList></Reference><Reference><Citation>Fibriansah G, Tan JL, Smith SA, de Alwis R, Ng TS, Kostyuchenko VA, Jadi RS, Kukkaro P, de Silva AM, Crowe JE, Lok SM. A highly potent human antibody neutralizes dengue virus serotype 3 by binding across three surface proteins. Nature Communications. 2015b;6:6341. doi: 10.1038/ncomms7341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms7341</ArticleId><ArticleId IdType="pmc">PMC4346626</ArticleId><ArticleId IdType="pubmed">25698059</ArticleId></ArticleIdList></Reference><Reference><Citation>Flipse J, Smit JM. The Complexity of a Dengue Vaccine: A Review of the Human Antibody Response. PLoS Neglected Tropical Diseases. 2015;9:e0003749. doi: 10.1371/journal.pntd.0003749.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003749</ArticleId><ArticleId IdType="pmc">PMC4465930</ArticleId><ArticleId IdType="pubmed">26065421</ArticleId></ArticleIdList></Reference><Reference><Citation>Fornili A, Autore F, Chakroun N, Martinez P, Fraternali F. Protein-water interactions in MD simulations: pops/POPSCOMP solvent accessibility analysis, solvation forces and hydration sites. Methods in Molecular Biology. 2012;819:375&#x2013;392. doi: 10.1007/978-1-61779-465-0_23.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/978-1-61779-465-0_23</ArticleId><ArticleId IdType="pubmed">22183548</ArticleId></ArticleIdList></Reference><Reference><Citation>Galula JU, Shen WF, Chuang ST, Chang GJ, Chao DY. Virus-like particle secretion and genotype-dependent immunogenicity of dengue virus serotype 2 DNA vaccine. Journal of Virology. 2014;88:10813&#x2013;10830. doi: 10.1128/JVI.00810-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00810-14</ArticleId><ArticleId IdType="pmc">PMC4178884</ArticleId><ArticleId IdType="pubmed">25008922</ArticleId></ArticleIdList></Reference><Reference><Citation>Guy B, Jackson N. Dengue vaccine: hypotheses to understand CYD-TDV-induced protection. Nature Reviews Microbiology. 2016;14:45&#x2013;54. doi: 10.1038/nrmicro.2015.2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrmicro.2015.2</ArticleId><ArticleId IdType="pubmed">26639777</ArticleId></ArticleIdList></Reference><Reference><Citation>Halstead SB. Dengvaxia sensitizes seronegatives to vaccine enhanced disease regardless of age. Vaccine. 2017;35:6355&#x2013;6358. doi: 10.1016/j.vaccine.2017.09.089.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.09.089</ArticleId><ArticleId IdType="pubmed">29029938</ArticleId></ArticleIdList></Reference><Reference><Citation>Henein S, Swanstrom J, Byers AM, Moser JM, Shaik SF, Bonaparte M, Jackson N, Guy B, Baric R, de Silva AM. Dissecting antibodies induced by a chimeric yellow Fever-Dengue, Live-Attenuated, tetravalent dengue vaccine (CYD-TDV) in naive and Dengue-Exposed individuals. The Journal of Infectious Diseases. 2017;215:351&#x2013;358. doi: 10.1093/infdis/jiw576.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw576</ArticleId><ArticleId IdType="pmc">PMC6392503</ArticleId><ArticleId IdType="pubmed">27932620</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang KJ, Yang YC, Lin YS, Huang JH, Liu HS, Yeh TM, Chen SH, Liu CC, Lei HY. The dual-specific binding of dengue virus and target cells for the antibody-dependent enhancement of dengue virus infection. The Journal of Immunology. 2006;176:2825&#x2013;2832. doi: 10.4049/jimmunol.176.5.2825.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.176.5.2825</ArticleId><ArticleId IdType="pubmed">16493039</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughes HR, Crill WD, Chang GJ. Manipulation of immunodominant dengue virus E protein epitopes reduces potential antibody-dependent enhancement. Virology Journal. 2012;9:115. doi: 10.1186/1743-422X-9-115.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-115</ArticleId><ArticleId IdType="pmc">PMC3424142</ArticleId><ArticleId IdType="pubmed">22709350</ArticleId></ArticleIdList></Reference><Reference><Citation>Junjhon J, Edwards TJ, Utaipat U, Bowman VD, Holdaway HA, Zhang W, Keelapang P, Puttikhunt C, Perera R, Chipman PR, Kasinrerk W, Malasit P, Kuhn RJ, Sittisombut N. Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles. Journal of Virology. 2010;84:8353&#x2013;8358. doi: 10.1128/JVI.00696-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00696-10</ArticleId><ArticleId IdType="pmc">PMC2916513</ArticleId><ArticleId IdType="pubmed">20519400</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzelnick LC, Coloma J, Harris E. Dengue: knowledge gaps, unmet needs, and research priorities. The Lancet Infectious Diseases. 2017;17:e88&#x2013;e100. doi: 10.1016/S1473-3099(16)30473-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1473-3099(16)30473-X</ArticleId><ArticleId IdType="pmc">PMC5967882</ArticleId><ArticleId IdType="pubmed">28185868</ArticleId></ArticleIdList></Reference><Reference><Citation>Keelapang P, Nitatpattana N, Suphatrakul A, Punyahathaikul S, Sriburi R, Pulmanausahakul R, Pichyangkul S, Malasit P, Yoksan S, Sittisombut N. Generation and preclinical evaluation of a DENV-1/2 prM+E chimeric live attenuated vaccine candidate with enhanced prM cleavage. Vaccine. 2013;31:5134&#x2013;5140. doi: 10.1016/j.vaccine.2013.08.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2013.08.027</ArticleId><ArticleId IdType="pubmed">23973247</ArticleId></ArticleIdList></Reference><Reference><Citation>Kirkpatrick BD, Whitehead SS, Pierce KK, Tibery CM, Grier PL, Hynes NA, Larsson CJ, Sabundayo BP, Talaat KR, Janiak A, Carmolli MP, Luke CJ, Diehl SA, Durbin AP. The live attenuated dengue vaccine TV003 elicits complete protection against dengue in a human challenge model. Science Translational Medicine. 2016;8:330ra36. doi: 10.1126/scitranslmed.aaf1517.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/scitranslmed.aaf1517</ArticleId><ArticleId IdType="pubmed">27089205</ArticleId></ArticleIdList></Reference><Reference><Citation>K&#xf6;hler G, Milstein C. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature. 1975;256:495&#x2013;497. doi: 10.1038/256495a0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/256495a0</ArticleId><ArticleId IdType="pubmed">1172191</ArticleId></ArticleIdList></Reference><Reference><Citation>Kostyuchenko VA, Zhang Q, Tan JL, Ng TS, Lok SM. Immature and mature dengue serotype 1 virus structures provide insight into the maturation process. Journal of Virology. 2013;87:7700&#x2013;7707. doi: 10.1128/JVI.00197-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00197-13</ArticleId><ArticleId IdType="pmc">PMC3700294</ArticleId><ArticleId IdType="pubmed">23637416</ArticleId></ArticleIdList></Reference><Reference><Citation>Li L, Lok SM, Yu IM, Zhang Y, Kuhn RJ, Chen J, Rossmann MG. The flavivirus precursor membrane-envelope protein complex: structure and maturation. Science. 2008;319:1830&#x2013;1834. doi: 10.1126/science.1153263.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1153263</ArticleId><ArticleId IdType="pubmed">18369147</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PC, Liao MY, Cheng PC, Liang JJ, Liu IJ, Chiu CY, Lin YL, Chang GJ, Wu HC. Development of a humanized antibody with high therapeutic potential against dengue virus type 2. PLoS Neglected Tropical Diseases. 2012;6:e1636. doi: 10.1371/journal.pntd.0001636.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0001636</ArticleId><ArticleId IdType="pmc">PMC3341331</ArticleId><ArticleId IdType="pubmed">22563515</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang JJ, Liao CL, Liao JT, Lee YL, Lin YL. A Japanese encephalitis virus vaccine candidate strain is attenuated by decreasing its interferon antagonistic ability. Vaccine. 2009;27:2746&#x2013;2754. doi: 10.1016/j.vaccine.2009.03.007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2009.03.007</ArticleId><ArticleId IdType="pubmed">19366580</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindenbach BD, Rice CM. In: "Flaviviridae: The Viruses and Their Replication." in Fields' Virology. Knipe D. M, Howley P. M, editors. Vol. 4. &#xa0;Lippincott Williams &amp; Wilkins, Philadelphia; 2001.</Citation></Reference><Reference><Citation>Lok SM, Kostyuchenko V, Nybakken GE, Holdaway HA, Battisti AJ, Sukupolvi-Petty S, Sedlak D, Fremont DH, Chipman PR, Roehrig JT, Diamond MS, Kuhn RJ, Rossmann MG. Binding of a neutralizing antibody to dengue virus alters the arrangement of surface glycoproteins. Nature Structural &amp; Molecular Biology. 2008;15:312&#x2013;317. doi: 10.1038/nsmb.1382.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.1382</ArticleId><ArticleId IdType="pubmed">18264114</ArticleId></ArticleIdList></Reference><Reference><Citation>Lok SM. The interplay of dengue virus morphological diversity and human antibodies. Trends in Microbiology. 2016;24:284&#x2013;293. doi: 10.1016/j.tim.2015.12.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.tim.2015.12.004</ArticleId><ArticleId IdType="pubmed">26747581</ArticleId></ArticleIdList></Reference><Reference><Citation>Lorenz IC, Kartenbeck J, Mezzacasa A, Allison SL, Heinz FX, Helenius A. Intracellular assembly and secretion of recombinant subviral particles from tick-borne encephalitis virus. Journal of Virology. 2003;77:4370&#x2013;4382. doi: 10.1128/JVI.77.7.4370-4382.2003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.77.7.4370-4382.2003</ArticleId><ArticleId IdType="pmc">PMC150630</ArticleId><ArticleId IdType="pubmed">12634393</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz SW, Gallichotte EN, Brackbill A, Premkumar L, Miley MJ, Baric R, de Silva AM. In vitro assembly and stabilization of dengue and zika virus envelope protein Homo-Dimers. Scientific Reports. 2017;7:4524. doi: 10.1038/s41598-017-04767-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-04767-6</ArticleId><ArticleId IdType="pmc">PMC5495877</ArticleId><ArticleId IdType="pubmed">28674411</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz SW, Thomas A, White L, Stoops M, Corten M, Hannemann H, de Silva AM. Dengue virus-like particles mimic the antigenic properties of the infectious dengue virus envelope. Virology Journal. 2018;15:60. doi: 10.1186/s12985-018-0970-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-018-0970-2</ArticleId><ArticleId IdType="pmc">PMC5879749</ArticleId><ArticleId IdType="pubmed">29609659</ArticleId></ArticleIdList></Reference><Reference><Citation>Modis Y, Ogata S, Clements D, Harrison SC. A ligand-binding pocket in the dengue virus envelope glycoprotein. PNAS. 2003;100:6986&#x2013;6991. doi: 10.1073/pnas.0832193100.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0832193100</ArticleId><ArticleId IdType="pmc">PMC165817</ArticleId><ArticleId IdType="pubmed">12759475</ArticleId></ArticleIdList></Reference><Reference><Citation>Moodie Z, Juraska M, Huang Y, Zhuang Y, Fong Y, Carpp LN, Self SG, Chambonneau L, Small R, Jackson N, Noriega F, Gilbert PB. Neutralizing antibody correlates analysis of tetravalent dengue vaccine efficacy trials in Asia and Latin America. The Journal of Infectious Diseases. 2018;217:742&#x2013;753. doi: 10.1093/infdis/jix609.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jix609</ArticleId><ArticleId IdType="pmc">PMC5854020</ArticleId><ArticleId IdType="pubmed">29194547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson S, Jost CA, Xu Q, Ess J, Martin JE, Oliphant T, Whitehead SS, Durbin AP, Graham BS, Diamond MS, Pierson TC. Maturation of West Nile virus modulates sensitivity to antibody-mediated neutralization. PLoS Pathogens. 2008;4:e1000060. doi: 10.1371/journal.ppat.1000060.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000060</ArticleId><ArticleId IdType="pmc">PMC2330159</ArticleId><ArticleId IdType="pubmed">18464894</ArticleId></ArticleIdList></Reference><Reference><Citation>Ohtaki N, Takahashi H, Kaneko K, Gomi Y, Ishikawa T, Higashi Y, Kurata T, Sata T, Kojima A. Immunogenicity and efficacy of two types of west nile virus-like particles different in size and maturation as a second-generation vaccine candidate. Vaccine. 2010;28:6588&#x2013;6596. doi: 10.1016/j.vaccine.2010.07.055.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2010.07.055</ArticleId><ArticleId IdType="pubmed">20678586</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Fremont DH, Kuhn RJ, Diamond MS. Structural insights into the mechanisms of antibody-mediated neutralization of flavivirus infection: implications for vaccine development. Cell Host &amp; Microbe. 2008;4:229&#x2013;238. doi: 10.1016/j.chom.2008.08.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2008.08.004</ArticleId><ArticleId IdType="pmc">PMC2678546</ArticleId><ArticleId IdType="pubmed">18779049</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierson TC, Diamond MS. Degrees of maturity: the complex structure and biology of flaviviruses. Current Opinion in Virology. 2012;2:168&#x2013;175. doi: 10.1016/j.coviro.2012.02.011.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.coviro.2012.02.011</ArticleId><ArticleId IdType="pmc">PMC3715965</ArticleId><ArticleId IdType="pubmed">22445964</ArticleId></ArticleIdList></Reference><Reference><Citation>Purdy DE, Chang GJ. Secretion of noninfectious dengue virus-like particles and identification of amino acids in the stem region involved in intracellular retention of envelope protein. Virology. 2005;333:239&#x2013;250. doi: 10.1016/j.virol.2004.12.036.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2004.12.036</ArticleId><ArticleId IdType="pubmed">15721358</ArticleId></ArticleIdList></Reference><Reference><Citation>Rey FA, Stiasny K, Vaney MC, Dellarole M, Heinz FX. The bright and the dark side of human antibody responses to flaviviruses: lessons for vaccine design. EMBO Reports. 2018;19:206&#x2013;224. doi: 10.15252/embr.201745302.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embr.201745302</ArticleId><ArticleId IdType="pmc">PMC5797954</ArticleId><ArticleId IdType="pubmed">29282215</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert IA, van der Schaar HM, da Silva Voorham JM, van der Ende-Metselaar H, Lei HY, Wilschut J, Smit JM. Immature dengue virus: a veiled pathogen? PLoS Pathogens. 2010;6:e1000718. doi: 10.1371/journal.ppat.1000718.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1000718</ArticleId><ArticleId IdType="pmc">PMC2798752</ArticleId><ArticleId IdType="pubmed">20062797</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert IA, Moesker B, da Silva Voorham JM, van der Ende-Metselaar H, Diamond MS, Wilschut J, Smit JM. A fusion-loop antibody enhances the infectious properties of immature Flavivirus particles. Journal of Virology. 2011;85:11800&#x2013;11808. doi: 10.1128/JVI.05237-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.05237-11</ArticleId><ArticleId IdType="pmc">PMC3209313</ArticleId><ArticleId IdType="pubmed">21880758</ArticleId></ArticleIdList></Reference><Reference><Citation>Rodenhuis-Zybert IA, da Silva Voorham JM, Torres S, van de Pol D, Smit JM. Antibodies against immature virions are not a discriminating factor for dengue disease severity. PLoS Neglected Tropical Diseases. 2015;9:e0003564. doi: 10.1371/journal.pntd.0003564.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pntd.0003564</ArticleId><ArticleId IdType="pmc">PMC4356584</ArticleId><ArticleId IdType="pubmed">25760350</ArticleId></ArticleIdList></Reference><Reference><Citation>Roehrig JT. Antigenic structure of flavivirus proteins. Advances in Virus Research. 2003;59:141&#x2013;175. doi: 10.1016/S0065-3527(03)59005-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0065-3527(03)59005-4</ArticleId><ArticleId IdType="pubmed">14696329</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouvinski A, Guardado-Calvo P, Barba-Spaeth G, Duquerroy S, Vaney MC, Kikuti CM, Navarro Sanchez ME, Dejnirattisai W, Wongwiwat W, Haouz A, Girard-Blanc C, Petres S, Shepard WE, Despr&#xe8;s P, Arenzana-Seisdedos F, Dussart P, Mongkolsapaya J, Screaton GR, Rey FA. Recognition determinants of broadly neutralizing human antibodies against dengue viruses. Nature. 2015;520:109&#x2013;113. doi: 10.1038/nature14130.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature14130</ArticleId><ArticleId IdType="pubmed">25581790</ArticleId></ArticleIdList></Reference><Reference><Citation>Rouvinski A, Dejnirattisai W, Guardado-Calvo P, Vaney MC, Sharma A, Duquerroy S, Supasa P, Wongwiwat W, Haouz A, Barba-Spaeth G, Mongkolsapaya J, Rey FA, Screaton GR. Covalently linked dengue virus envelope glycoprotein dimers reduce exposure of the immunodominant fusion loop epitope. Nature Communications. 2017;8:15411. doi: 10.1038/ncomms15411.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms15411</ArticleId><ArticleId IdType="pmc">PMC5457521</ArticleId><ArticleId IdType="pubmed">28534525</ArticleId></ArticleIdList></Reference><Reference><Citation>Sch&#xe4;gger H. Tricine-SDS-PAGE. Nature Protocols. 2006;1:16&#x2013;22. doi: 10.1038/nprot.2006.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nprot.2006.4</ArticleId><ArticleId IdType="pubmed">17406207</ArticleId></ArticleIdList></Reference><Reference><Citation>Sorzano CO, Marabini R, Vel&#xe1;zquez-Muriel J, Bilbao-Castro JR, Scheres SH, Carazo JM, Pascual-Montano A. XMIPP: a new generation of an open-source image processing package for electron microscopy. Journal of Structural Biology. 2004;148:194&#x2013;204. doi: 10.1016/j.jsb.2004.06.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2004.06.006</ArticleId><ArticleId IdType="pubmed">15477099</ArticleId></ArticleIdList></Reference><Reference><Citation>Suphatrakul A, Yasanga T, Keelapang P, Sriburi R, Roytrakul T, Pulmanausahakul R, Utaipat U, Kawilapan Y, Puttikhunt C, Kasinrerk W, Yoksan S, Auewarakul P, Malasit P, Charoensri N, Sittisombut N. Generation and preclinical immunogenicity study of dengue type 2 virus-like particles derived from stably transfected mosquito cells. Vaccine. 2015;33:5613&#x2013;5622. doi: 10.1016/j.vaccine.2015.08.090.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2015.08.090</ArticleId><ArticleId IdType="pubmed">26382602</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang G, Peng L, Baldwin PR, Mann DS, Jiang W, Rees I, Ludtke SJ. EMAN2: an extensible image processing suite for electron microscopy. Journal of Structural Biology. 2007;157:38&#x2013;46. doi: 10.1016/j.jsb.2006.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jsb.2006.05.009</ArticleId><ArticleId IdType="pubmed">16859925</ArticleId></ArticleIdList></Reference><Reference><Citation>Tian S, Huajun W, Wu J. Computational prediction of furin cleavage sites by a hybrid method and understanding mechanism underlying diseases. Scientific Reports. 2012;2:261. doi: 10.1038/srep00261.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep00261</ArticleId><ArticleId IdType="pmc">PMC3281273</ArticleId><ArticleId IdType="pubmed">22355773</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai WY, Lai CY, Wu YC, Lin HE, Edwards C, Jumnainsong A, Kliks S, Halstead S, Mongkolsapaya J, Screaton GR, Wang WK. High-avidity and potently neutralizing cross-reactive human monoclonal antibodies derived from secondary dengue virus infection. Journal of Virology. 2013;87:12562&#x2013;12575. doi: 10.1128/JVI.00871-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00871-13</ArticleId><ArticleId IdType="pmc">PMC3838129</ArticleId><ArticleId IdType="pubmed">24027331</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Z, Li L, Pennington JG, Sheng J, Yap ML, Plevka P, Meng G, Sun L, Jiang W, Rossmann MG. Obstruction of dengue virus maturation by Fab fragments of the 2H2 antibody. Journal of Virology. 2013;87:8909&#x2013;8915. doi: 10.1128/JVI.00472-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00472-13</ArticleId><ArticleId IdType="pmc">PMC3754034</ArticleId><ArticleId IdType="pubmed">23740974</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO Dengue vaccine: who position paper, July 2016 - recommendations. Vaccine. 2017;35:1200&#x2013;1201. doi: 10.1016/j.vaccine.2016.10.070.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2016.10.070</ArticleId><ArticleId IdType="pubmed">28185744</ArticleId></ArticleIdList></Reference><Reference><Citation>Wichmann O, Vannice K, Asturias EJ, de Albuquerque Luna EJ, Longini I, Lopez AL, Smith PG, Tissera H, Yoon IK, Hombach J. Live-attenuated tetravalent dengue vaccines: The needs and challenges of post-licensure evaluation of vaccine safety and effectiveness. Vaccine. 2017;35:5535&#x2013;5542. doi: 10.1016/j.vaccine.2017.08.066.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2017.08.066</ArticleId><ArticleId IdType="pubmed">28893477</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Meng Y, Halloran ME, Longini IM. Dependency of vaccine efficacy on preexposure and age: a closer look at a tetravalent dengue vaccine. Clinical Infectious Diseases. 2018;66:178&#x2013;184. doi: 10.1093/cid/cix766.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/cix766</ArticleId><ArticleId IdType="pmc">PMC5850009</ArticleId><ArticleId IdType="pubmed">29020332</ArticleId></ArticleIdList></Reference><Reference><Citation>Zellweger RM, Prestwood TR, Shresta S. Enhanced infection of liver sinusoidal endothelial cells in a mouse model of antibody-induced severe dengue disease. Cell Host &amp; Microbe. 2010;7:128&#x2013;139. doi: 10.1016/j.chom.2010.01.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2010.01.004</ArticleId><ArticleId IdType="pmc">PMC2824513</ArticleId><ArticleId IdType="pubmed">20153282</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang SL, Tan HC, Hanson BJ, Ooi EE. A simple method for Alexa Fluor dye labelling of dengue virus. Journal of Virological Methods. 2010;167:172&#x2013;177. doi: 10.1016/j.jviromet.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jviromet.2010.04.001</ArticleId><ArticleId IdType="pubmed">20399231</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Ge P, Yu X, Brannan JM, Bi G, Zhang Q, Schein S, Zhou ZH. Cryo-EM structure of the mature dengue virus at 3.5-&#xc5; resolution. Nature Structural &amp; Molecular Biology. 2013a;20:105&#x2013;110. doi: 10.1038/nsmb.2463.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nsmb.2463</ArticleId><ArticleId IdType="pmc">PMC3593067</ArticleId><ArticleId IdType="pubmed">23241927</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Sheng J, Plevka P, Kuhn RJ, Diamond MS, Rossmann MG. Dengue structure differs at the temperatures of its human and mosquito hosts. PNAS. 2013b;110:6795&#x2013;6799. doi: 10.1073/pnas.1304300110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1304300110</ArticleId><ArticleId IdType="pmc">PMC3637732</ArticleId><ArticleId IdType="pubmed">23569243</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang X, Sheng J, Austin SK, Hoornweg TE, Smit JM, Kuhn RJ, Diamond MS, Rossmann MG. Structure of acidic pH dengue virus showing the fusogenic glycoprotein trimers. Journal of Virology. 2015;89:743&#x2013;750. doi: 10.1128/JVI.02411-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02411-14</ArticleId><ArticleId IdType="pmc">PMC4301137</ArticleId><ArticleId IdType="pubmed">25355881</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>